Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2005
06/22/2005EP1542992A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
06/22/2005EP1542991A1 Pyrimidine compounds as therapeutic agents
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
06/22/2005EP1542734A1 Isotopically labelled indolinone derivatives and process for their preparation
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1525265A4 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1630650A Nitrogenous heterocyclic compound and medicine thereof
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630644A Pyridine and pyrimidine derivatives
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1629157A Piperazinyl triazine compounds, preparation method thereof and pharmaceutical composition containing same
06/22/2005CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/22/2005CN1207287C Ester compounds of bezimidazole and their preparations and uses in preparation of medicinal compound
06/21/2005US6909437 Data driven layout engine
06/21/2005US6908996 Compounds and method for preparing 3-methylcephams
06/21/2005US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908936 Respiratory syncytial virus
06/21/2005US6908929 Central nervous system disorders
06/21/2005US6908922 Linear cyclic ureas
06/21/2005US6908921 Quinoxalinone derivatives as bradykinin B1 antagonists
06/21/2005US6908920 Pyrimidine derivatives
06/21/2005US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
06/16/2005WO2005054239A1 2-aminopyrimidine derivatives
06/16/2005WO2005054232A1 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders
06/16/2005WO2005054231A1 Pyrazolyl and imidazolyl pyrimidines
06/16/2005WO2005054230A1 Azole-based kinase inhibitors
06/16/2005WO2005054227A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
06/16/2005WO2005054212A2 Electroluminescent device
06/16/2005WO2005054209A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-­ribose) polymerase inhibitors
06/16/2005WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/16/2005WO2005054199A1 Tubulin inhibitors
06/16/2005WO2005054193A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
06/16/2005WO2005054188A1 Imidazole derivatives, processes for preparing them and their uses
06/16/2005WO2005053735A1 Method of removing transition metals, especially from metathesis reaction products
06/16/2005WO2005053686A1 Indolinone based protein kinase inhibitors
06/16/2005WO2005053614A2 Advanced indolinone based protein kinase inhibitors
06/16/2005WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer
06/16/2005WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors
06/16/2005WO2004046107A8 Indole derivatives as somatostatin agonists or antagonists
06/16/2005WO1990000853A8 Method of treating neurological disorders
06/16/2005US20050131237 Indole derivatives
06/16/2005US20050131050 Reacting ethyl trifluoroacetate with 4'fluoroacetophenone and 4-sulphonamidophenyl hydrazine
06/16/2005US20050131045 High melting crystal structure; heat resistance
06/16/2005US20050131044 Small molecule inhibitors of necrosis
06/16/2005US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
06/16/2005US20050131042 HIV protease inhibiting compounds
06/16/2005US20050131041 Using trizole or imidazole compound containing hydroxy group
06/16/2005US20050131040 Reacting losartan and poltassium compound in presence of water and aprotic solvent; salt formation
06/16/2005US20050131039 Benzimidazole derivatives, their production and use
06/16/2005US20050131037 Dehydrohalogenation to form cilexetin trityl candesartan in the presence of phase transfer compounds
06/16/2005US20050131019 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
06/16/2005US20050131002 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents
06/16/2005US20050131001 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130989 (3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)(4-phenylpiperazin-1-yl)methanone; inhibit tubulin polymerization; cancer
06/16/2005US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders
06/16/2005US20050130978 Novel crystal of quinoxalinedione derivative anhydride
06/16/2005US20050130977 Inhibitors of akt activity
06/16/2005US20050130976 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130953 Pharmacological uses of azetidine derivatives
06/16/2005US20050130943 Bicyclic inhibitors of MEK and methods of use thereof
06/16/2005US20050130940 Fungal infections; water soluble phosphate derivatives of triazole drugs such as fluconazole
06/16/2005US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening
06/16/2005US20050130225 Ecstasy haptens and immunogens
06/16/2005US20050127823 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
06/16/2005US20050127337 Chromophore comprising pyrimidin-2,4,6-trione and/or pyrrolidinedione/2,5-/ derivative with diaminomelamine or aminopurinone groups; quality, thickness; electrooptic films; acentric microstructure
06/16/2005CA2857067A1 Tubulin inhibitors
06/16/2005CA2549119A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
06/16/2005CA2547887A1 Protein modifier production inhibitor
06/16/2005CA2547066A1 Advanced indolinone based protein kinase inhibitors
06/16/2005CA2545992A1 Pyrazolyl and imidazolyl pyrimidines
06/16/2005CA2545425A1 Azole-based kinase inhibitors
06/16/2005CA2545422A1 Tubulin inhibitors
06/16/2005CA2539575A1 Method of removing transition metals, especially from metathesis reaction products
06/15/2005EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt
06/15/2005EP1541143A1 Dpp-iv inhibitors
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539740A1 Sulphonamide derivatives and their use as tace inhibitors
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539733A2 Azabicyclic compounds are central nervous system active agents
06/15/2005EP1539718A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539712A1 Pyrimidine derivatives and their use as cb2 modulators
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539709A1 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539705A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
06/15/2005EP1539704A1 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
06/15/2005EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation
06/15/2005EP1539180A2 Compounds, compositions, and methods
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 626